U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07286149) titled 'A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)' on Nov. 17.
Brief Summary: Researchers want to learn if MK-1084, the study medicine, can treat advanced or metastatic non-squamous NSCLC. MK-1084 is a targeted therapy, which is a treatment that works to control how specific types of cancer cells grow and spread. The goals of this study are to learn:
* About the safety of MK-1084 and if people tolerate it when taken with other treatments
* How many people have the cancer respond (get smaller or go away) to the treatments
Study Start Date: Feb. 09, 2026
Study Type: INTERVENTIONAL
Cond...